| officinali, Melissa |
| officinali, Pimenta |
| officinali, Rosmarinus |
| officinali, Salvia |
| officinali, Saponaria |
| officinali, Valeriana |
| officinalin isobutyrate |
| officinalis, Asparagus |
| officinalis, Calendula |
| officinalis, Emblica |
| officinalis, Galega |
| officinalis, Magnolia |
| officinalis, Melissa |
| officinalis, Pimenta |
| officinalis, Rosmarinus |
| officinalis, Salvia |
| officinalis, Saponaria |
| officinalis, Valeriana |
| officious |
| officiously |
| officiousness |
| offing |
| offish |
| offishly |
| offline |
| offloaded |
| offloading |
| offloads |
| offprint |
| offprints |
| offs |
| Offset |
| offset (of a bed) |
| offset (seismics) |
| offset account |
| offset disc harrow |
| offset dish antenna |
| Offset knee joint each |
| Offset knee joint heavy duty |
| offset limit |
| offset of the bed |
| offset paper |
| offset planning |
| offset printing |
| offset printing paper |
| offset screwdriver |
| offset screwdrivers |
| offset wrench |
| offset} |
| Offset/lat rocker arm w/ ela |
| offseting |
| offsets |
| offsetting |
| offshoot |
| offshoots |
| offshore |
| offshore (wind) |
| offshore companies |
| offshore company |
| offshore place |
| offshore wind |
| offshore wind energy |
| offshoring |
| offside |
| offside goal |
| offside goals |
| offside rule |
| offside rules |
| offside trap |
| offsides |
| Offspring |
| Offspring do not have 'true' acrodermatitis enteropathica |
| offspring leaves home |
| Offspring of Impaired Parents |
| Offspring, Adult |
| Offspring, Multiple Birth |
| offstage |
| offtake |
| Ofisolona |
| OFK 006 |
| OFK006 |
| Ofloxacin |
| Ofloxacin [Chemical/Ingredient] |
| Ofloxacin [Mass] of Dose |
| Ofloxacin [Mass/volume] in Serum or Plasma |
| Ofloxacin [Mass/volume] in Unspecified specimen |
| Ofloxacin [Susceptibility] |
| Ofloxacin [Susceptibility] by Disk diffusion (KB) |
| Ofloxacin [Susceptibility] by Gradient strip (E-test) |
| Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria |
| Ofloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) |
| Ofloxacin [Susceptibility] by Minimum lethal concentration (MLC) |
| Ofloxacin [Susceptibility] by Serum bactericidal titer |
| OFLOXACIN @ 0.3-0.3% @ COMBINATION PACKAGE |
| OFLOXACIN @ 0.3% @ DROPS |
| OFLOXACIN @ 0.3% @ OINTMENT(GM) |
| OFLOXACIN @ 100MG @ TABLET |
| OFLOXACIN @ 200MG @ TABLET |
| OFLOXACIN @ 20MG/ML @ VIAL (SDV,MDV OR ADDITIVE) (ML) |
| OFLOXACIN @ 300MG @ TABLET |
| OFLOXACIN @ 400MG @ TABLET |
| OFLOXACIN @ 40MG/ML @ VIAL (SDV,MDV OR ADDITIVE) (ML) |
| OFLOXACIN @ 4MG/ML @ INTRAVENOUS SOLUTION |
| OFLOXACIN @ 4MG/ML @ VIAL (SDV,MDV OR ADDITIVE) (ML) |
| Ofloxacin | isolate |
| Ofloxacin | isolate & serum |
| ofloxacin 0.3 % Opthalmic Solution |
| ofloxacin 0.3 % Otic Solution |
| OFLOXACIN 0.3 %VV AURICULAR (OTIC) SOLUTION |
| OFLOXACIN 0.3 %VV OPHTHALMIC SOLUTION |
| OFLOXACIN 0.3 %VV OPHTHALMIC SOLUTION [OFLAXACIN] |
| OFLOXACIN 0.3 %VV OPHTHALMIC SOLUTION [OFLOXAZIN] |
| OFLOXACIN 0.3 %WV OPHTHALMIC SOLUTION |
| OFLOXACIN 0.3 %WV OPHTHALMIC SOLUTION [OCUFLOX] |
| OFLOXACIN 0.3 %WW / OFLOXACIN 3 MG OPHTHALMIC SOLUTION |
| OFLOXACIN 0.3 %WW AURICULAR (OTIC) SOLUTION |
| OFLOXACIN 0.3 %WW AURICULAR (OTIC) SOLUTION [OFLAXCIN] |
| OFLOXACIN 0.3 %WW OPHTHALMIC SOLUTION |
| OFLOXACIN 0.3 %WW TOPICAL SOLUTION [OFLXACIN] |
| OFLOXACIN 0.3-0.3% COMBINATION PACKAGE |
| OFLOXACIN 0.3% DROPS |
| OFLOXACIN 0.3% OINTMENT(GM) |
| OFLOXACIN 0.3% OPH SOLN |
| OFLOXACIN 0.3% Ophthalmic (non-systemic) solution |
| OFLOXACIN 0.3% OPHTHALMIC DROPS |
| Ofloxacin 0.3% Ophthalmic Solution [OCUFLOX] |
| OFLOXACIN 0.3% OTIC DROPPERETTE, SINGLE-USE DROP DISPENSER |
| OFLOXACIN 0.3% OTIC DROPS |
| OFLOXACIN 0.3% OTIC SOLN |
| OFLOXACIN 0.3% Otic solution |
| OFLOXACIN 0.3% SOLN,OPH |
| OFLOXACIN 0.3% SOLN,OPH [VA Product] |
| OFLOXACIN 0.3% SOLN,OTIC |
| OFLOXACIN 0.3% SOLN,OTIC [VA Product] |
| Ofloxacin 1 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| Ofloxacin 1 ug/mL Islt SlowMyco |
| Ofloxacin 1.0 ug/mL |
| Ofloxacin 1.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria |
| Ofloxacin 1.0 ug/mL:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Method for Slow-growing mycobacteria |
| Ofloxacin 100 MG |
| Ofloxacin 100 MG Oral Tablet |
| OFLOXACIN 100MG TABLET |
| Ofloxacin 2 MG/ML |
| Ofloxacin 2 MG/ML Injectable Solution |
| Ofloxacin 2 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| Ofloxacin 2 ug/mL Islt SlowMyco |
| Ofloxacin 2.0 ug/mL |
| Ofloxacin 2.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria |
| Ofloxacin 2.0 ug/mL:Susc:Pt:Isolate:OrdQn:Slow-growing Mycobacteria |
| Ofloxacin 2.0 ug/mL:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Method for Slow-growing mycobacteria |
| Ofloxacin 2.0 ug/mL:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Slow-growing Mycobacteria |
| Ofloxacin 20 MG/ML |
| Ofloxacin 20 MG/ML [Floxin] |
| Ofloxacin 20 MG/ML Injectable Solution |
| Ofloxacin 20 MG/ML Injectable Solution [Floxin] |
| OFLOXACIN 20 mg/mL INTRAVEN. VIAL (SDV,MDV OR ADDITIVE) (ML) |
| ofloxacin 20 mg/mL intravenous solution |
| Ofloxacin 200 MG |
| Ofloxacin 200 MG [Floxin] |
| OFLOXACIN 200 MG Oral (systemic) tablet |
| Ofloxacin 200 MG Oral Tablet |
| Ofloxacin 200 MG Oral Tablet [Floxin] |
| OFLOXACIN 200 MG ORAL TABLET, COATED |
| OFLOXACIN 200 MG ORAL TABLET, COATED [FLOXIN] |
| OFLOXACIN 200 MG ORAL TABLET, FILM COATED |
| OFLOXACIN 200 MG ORAL TABLET, FILM COATED [FLOXIN] |
| Ofloxacin 200 MILLIGRAM In 1 TABLET ORAL TABLET |
| ofloxacin 200 MILLIGRAM In 1 TABLET ORAL TABLET, COATED [Floxin] |
| ofloxacin 200 MILLIGRAM In 1 TABLET ORAL TABLET, FILM COATED |
| OFLOXACIN 200MG ORAL TABLET |
| OFLOXACIN 200MG TAB |
| OFLOXACIN 200MG TAB [VA Product] |
| OFLOXACIN 200MG TABLET |
| OFLOXACIN 20MG/ML INJ |
| OFLOXACIN 20MG/ML INJ [VA Product] |
| OFLOXACIN 20MG/ML INTRAVEN. VIAL (SDV,MDV OR ADDITIVE) (ML) |
| OFLOXACIN 20MG/ML VIAL (SDV,MDV OR ADDITIVE) (ML) |
| OFLOXACIN 3 %WV CONJUNCTIVAL SOLUTION |
| OFLOXACIN 3 %WV OPHTHALMIC SOLUTION |
| OFLOXACIN 3 MG AURICULAR (OTIC) LIQUID |
| OFLOXACIN 3 MG AURICULAR (OTIC) LIQUID [FLOXIN] |
| OFLOXACIN 3 MG AURICULAR (OTIC) SOLUTION |
| OFLOXACIN 3 MG AURICULAR (OTIC) SOLUTION [FLOXIN] |
| OFLOXACIN 3 MG AURICULAR (OTIC) SOLUTION [OFLAXCIN] |
| OFLOXACIN 3 mg in 1 mL AURICULAR (OTIC) SOLUTION |
| OFLOXACIN 3 mg in 1 mL AURICULAR (OTIC) SOLUTION/ DROPS [Ofloxacin] |
| ofloxacin 3 mg in 1 mL OPHTHALMIC SOLUTION |
| OFLOXACIN 3 mg in 1 mL OPHTHALMIC SOLUTION/ DROPS |
| OFLOXACIN 3 MG INTRAVENOUS BOLUS SOLUTION |
| OFLOXACIN 3 MG OPHTHALMIC SOLUTION |
| Ofloxacin 3 MG/ML |
| Ofloxacin 3 MG/ML [Floxin] |
| Ofloxacin 3 MG/ML [Ocuflox] |
| Ofloxacin 3 MG/ML Ophthalmic Solution |
| Ofloxacin 3 MG/ML Ophthalmic Solution [Ocuflox] |
| Ofloxacin 3 MG/ML Otic Solution |
| Ofloxacin 3 MG/ML Otic Solution [Floxin] |
| Ofloxacin 3 MILLIGRAM In 1 MILLILITER AURICULAR (OTIC) SOLUTION [FLOXIN] |
| ofloxacin 3 MILLIGRAM In 1 MILLILITER OPHTHALMIC SOLUTION [OCUFLOX] |
| ofloxacin 3 MILLIGRAM In 1 MILLILITER OPHTHALMIC SOLUTION [Ofloxacin] |
| OFLOXACIN 3 MILLIGRAM In 1 MILLILITER OPHTHALMIC SOLUTION/ DROPS |
| Ofloxacin 30 MG/ML |
| Ofloxacin 30 MG/ML Otic Solution |
| Ofloxacin 300 MG |
| Ofloxacin 300 MG [Floxin] |
| OFLOXACIN 300 MG / OFLOXACIN 400 MG ORAL TABLET, COATED [FLOXIN] |
| OFLOXACIN 300 MG / OFLOXACIN 400 MG ORAL TABLET, FILM COATED [FLOXIN] |
| OFLOXACIN 300 MG Oral (systemic) tablet |
| Ofloxacin 300 MG Oral Tablet |
| Ofloxacin 300 MG Oral Tablet [Floxin] |
| OFLOXACIN 300 MG ORAL TABLET, COATED |
| OFLOXACIN 300 MG ORAL TABLET, COATED [FLOXIN] |
| OFLOXACIN 300 MG ORAL TABLET, FILM COATED |
| OFLOXACIN 300 MG ORAL TABLET, FILM COATED [FLOXIN] |
| Ofloxacin 300 MILLIGRAM In 1 TABLET ORAL TABLET |
| ofloxacin 300 MILLIGRAM In 1 TABLET ORAL TABLET, COATED [Floxin] |
| ofloxacin 300 MILLIGRAM In 1 TABLET ORAL TABLET, FILM COATED |
| OFLOXACIN 300MG ORAL TABLET |
| OFLOXACIN 300MG TAB |
| OFLOXACIN 300MG TAB [VA Product] |
| OFLOXACIN 300MG TABLET |
| Ofloxacin 3mg/mL solution |
| Ofloxacin 3mg/mL solution (product) |
| Ofloxacin 4 MG/ML |
| Ofloxacin 4 MG/ML [Floxin] |
| Ofloxacin 4 MG/ML Injectable Solution |
| Ofloxacin 4 MG/ML Injectable Solution [Floxin] |
| ofloxacin 4 mg/mL intravenous solution |
| Ofloxacin 4 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria |
| Ofloxacin 4 ug/mL Islt SlowMyco |
| Ofloxacin 4.0 ug/mL |
| Ofloxacin 4.0 ug/mL:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria |
| Ofloxacin 4.0 ug/mL:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Method for Slow-growing mycobacteria |
| Ofloxacin 40 MG/ML |
| Ofloxacin 40 MG/ML [Floxin] |
| Ofloxacin 40 MG/ML Injectable Solution |
| Ofloxacin 40 MG/ML Injectable Solution [Floxin] |
| OFLOXACIN 40 mg/mL INTRAVEN. VIAL (SDV,MDV OR ADDITIVE) (ML) |
| ofloxacin 40 mg/mL intravenous solution |
| Ofloxacin 400 MG |
| Ofloxacin 400 MG [Floxin] |
| OFLOXACIN 400 MG Oral (systemic) tablet |
| Ofloxacin 400 MG Oral Tablet |
| Ofloxacin 400 MG Oral Tablet [Floxin] |
| OFLOXACIN 400 MG ORAL TABLET, FILM COATED |
| OFLOXACIN 400 MG ORAL TABLET, FILM COATED [FLOXIN] |
| OFLOXACIN 400 MG ORAL TABLET, FILM COATED [OFLOXCIN] |
| Ofloxacin 400 MILLIGRAM In 1 TABLET ORAL TABLET |
| ofloxacin 400 MILLIGRAM In 1 TABLET ORAL TABLET, COATED [Floxin] |
| ofloxacin 400 MILLIGRAM In 1 TABLET ORAL TABLET, FILM COATED |
| OFLOXACIN 400MG ORAL TABLET |
| OFLOXACIN 400MG TAB |
| OFLOXACIN 400MG TAB [VA Product] |
| OFLOXACIN 400MG TABLET |
| OFLOXACIN 40MG/ML INJ |
| OFLOXACIN 40MG/ML INJ [VA Product] |
| OFLOXACIN 40MG/ML INTRAVEN. VIAL (SDV,MDV OR ADDITIVE) (ML) |
| OFLOXACIN 40MG/ML INTRAVENOUS VIAL (SDV,MDV OR ADDITIVE) (ML) |
| OFLOXACIN 40MG/ML VIAL (SDV,MDV OR ADDITIVE) (ML) |
| OFLOXACIN 4MG/ML INJ |
| OFLOXACIN 4MG/ML INJ [VA Product] |
| OFLOXACIN 4MG/ML INTRAVENOUS SOLUTION |
| OFLOXACIN 4MG/ML VIAL (SDV,MDV OR ADDITIVE) (ML) |
| OFLOXACIN 4MG/ML/D5W INJ BAG 50ML |
| OFLOXACIN 4MG/ML/D5W INJ,BAG,50ML |
| OFLOXACIN 4MG/ML/D5W INJ,BAG,50ML [VA Product] |
| Ofloxacin 5 MG/ML |
| Ofloxacin 5 MG/ML Injectable Solution |
| Ofloxacin 600 MG |
| Ofloxacin 600 MG Oral Tablet |
| Ofloxacin Dose |
| OFLOXACIN HCL @ 100MG @ INTRAVENOUS SOLUTION |
| OFLOXACIN HCL @ 2MG/ML @ INTRAVENOUS SOLUTION |
| OFLOXACIN HCL 100MG INTRAVENOUS SOLUTION |
| OFLOXACIN HCL 2MG/ML INTRAVENOUS SOLUTION |
| Ofloxacin Hydrochloride |
| Ofloxacin in D5W 4 MG/ML |
| Ofloxacin Injectable Solution |
| Ofloxacin Injectable Solution [Floxin] |
| Ofloxacin Islt E-test |
| Ofloxacin Islt KB |
| Ofloxacin Islt MIC |
| Ofloxacin Islt MLC |
| Ofloxacin Islt SlowMyco |
| Ofloxacin IV Soln 20 MG/ML |
| Ofloxacin IV Soln 200 MG/100ML |
| Ofloxacin IV Soln 40 MG/ML |
| ofloxacin N-oxide |
| ofloxacin N-oxide, (+-)-isomer |
| ofloxacin O-glucuronide |
| ofloxacin ophthalmic |
| ofloxacin ophthalmic 0.3% ophthalmic solution |
| Ofloxacin Ophthalmic Solution |
| Ofloxacin Ophthalmic Solution [Ocuflox] |
| Ofloxacin Ophthalmic, 0.3% ophthalmic solution |
| Ofloxacin Oral Tablet |
| Ofloxacin Oral Tablet [Floxin] |
| ofloxacin otic |
| ofloxacin otic 0.3% otic solution |
| Ofloxacin Otic Solution |
| Ofloxacin Otic Solution [Floxin] |
| Ofloxacin Otic, 0.3% otic solution |
| ofloxacin pivaloyloxymethyl ester |
| Ofloxacin SerPl-mCnc |
| Ofloxacin Susc Islt |
| Ofloxacin Titr SBT |
| Ofloxacin XXX-mCnc |
| Ofloxacin, (S)-Isomer |
| Ofloxacin, 200 mg oral tablet |
| Ofloxacin, 300 mg oral tablet |
| Ofloxacin, 400 mg oral tablet |
| Ofloxacin:Dilution Factor (Titer):Point in time:Isolate+Serum:Quantitative:SERUM BACTERIAL TITER |
| Ofloxacin:Mass Concentration:Point in time:Serum/Plasma:Quantitative |
| Ofloxacin:Mass Concentration:Point in time:To be specified in another part of the message:Quantitative |
| Ofloxacin:Mass:Point in time:Dose med or substance:Quantitative |
| Ofloxacin:Mass:Pt:Dose:Qn |
| Ofloxacin:MCnc:Pt:Ser/Plas:Qn |
| Ofloxacin:MCnc:Pt:XXX:Qn |
| Ofloxacin:Susc:Pt:Isolate:OrdQn |
| Ofloxacin:Susc:Pt:Isolate:OrdQn:Agar diffusion |
| Ofloxacin:Susc:Pt:Isolate:OrdQn:Gradient strip |
| Ofloxacin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria |
| Ofloxacin:Susc:Pt:Isolate:OrdQn:MIC |
| Ofloxacin:Susc:Pt:Isolate:OrdQn:Slow-growing Mycobacteria |
| Ofloxacin:Susc:Pt:Isolate:Qn:MLC |
| Ofloxacin:Susceptibility:Point in time:Isolate:Quantitative or Ordinal |
| Ofloxacin:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Agar diffusion |
| Ofloxacin:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Gradient strip |
| Ofloxacin:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Method for Slow-growing mycobacteria |
| Ofloxacin:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:MINIMUM INHIBITORY CONCENTRATION |
| Ofloxacin:Susceptibility:Point in time:Isolate:Quantitative or Ordinal:Slow-growing Mycobacteria |
| Ofloxacin:Susceptibility:Point in time:Isolate:Quantitative:MINIMUM LETHAL CONCENTRATION |
| Ofloxacin:Titr:Pt:Isolate+Ser:Qn:SBT |
| [email protected]%@[email protected] |
| [email protected]%@[email protected], SINGLE-USE DROP DISPENSER |
| [email protected]%@[email protected] |
| [email protected] mg/[email protected]@VIAL (SDV,MDV OR ADDITIVE) (ML) |
| [email protected]@[email protected] |
| [email protected]/[email protected]@VIAL (SDV,MDV OR ADDITIVE) (ML) |
| [email protected]@[email protected] |
| [email protected] mg/[email protected]@VIAL (SDV,MDV OR ADDITIVE) (ML) |
| [email protected]@[email protected] |
| [email protected]/[email protected]@VIAL (SDV,MDV OR ADDITIVE) (ML) |
| OFLOXACIN/DEXTROSE 5%-WATER @ 4MG/ML @ INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%-WATER 200 mg/50 mL INTRAVEN. INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%-WATER 200MG/50ML INTRAVEN. INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%-WATER 4 mg/mL INTRAVEN. INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%-WATER 400 mg/100 mL INTRAVEN. INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%-WATER 400MG/0.1L INTRAVEN. INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%-WATER 4MG/ML INTRAVEN. INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%-WATER 4MG/ML INTRAVENOUS INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%-WATER 4MG/ML INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%[email protected] mg/50 [email protected]@INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%[email protected]/[email protected]@INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%[email protected] mg/[email protected]@INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%[email protected] mg/100 [email protected]@INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%[email protected]/[email protected]@INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/DEXTROSE 5%[email protected]/[email protected]@INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/SODIUM @ 200MG/40ML @ INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| OFLOXACIN/SODIUM 200MG/40ML INTRAVENOUS SOLUTION, PIGGYBACK (ML) |
| Ofloxacine |
| oFLU cpd |
| OFLX glucuronide |
| OFMHA |
| OFORA |
| OFORB |
| Oforta |
| Oforta 10 MG Oral Tablet |
| Oforta, 10 mg oral tablet |
| OFP-BE |
| OFP1 protein, Arabidopsis |
| OFPNPG cpd |
| OFQ -N (154-181) |
| OFQ N(1-11) |
| OFQ N(1-6) |
| OFQ receptor |
| OFQ receptors |
| Ofs protein, Drosophila |
| OFT 36PC 1 %/1 % |
| oftake |
| Oftalar |
| Oftan IDU |
| Oftan-IDU |
| OftanIDU |
| Oftanol |
| Oftasceine Disodium |
| often |
| Often an infecting organism cannot be identified |
| Often associated with Chiari type I malformation (CM1, {118420}) |
| Often associated with Klippel-Feil anomaly ({118100}) |
| Often associated with syringomyelia ({186700}) |
| Often confused with tuberous sclerosis ({191000}) |
| Often diagnosed between ages 3-4 months |
| often enough |
| Often fatal due in infancy due to intractable diarrhea |
| Often fatal in utero |
| Often identified in newborn period |
| Often integrated HBV sequences in hepatocellular carcinomas |
| Often lethal in infancy |
| Often presents with cranial or cervical involvement |
| Often reared as females until puberty |
| Often refractory to medical therapy |
| often repeated |
| Often stillborn |
| Often unilateral involvement |
| often used |
| oftentimes |
| Oftia |
| Oftia africana |
| ofttimes |
| OFU 001 |
| OFU001 |
| OFUCT1 |
| Ofunack |
| ofurace |
| OFUT1 |
| OFUT1 protein, Drosophila |
| OG |
| OG 37-325 |
| OG 514 |
| OG-12 protein, mouse |
| OG-12A protein, mouse |
| OG-12B protein, mouse |
| OG-2 protein, human |
| OG-514 |
| OG-VI solution |
| OG12 |
| OG12 protein, human |
| OG12X |
| OG12X protein, mouse |
| OG2 |
| OG2 homeobox gene, mouse |
| OG2 protein, human |
| Og2x |
| Og2x protein, mouse |
| OG37-325 |
| OG9 |
| OG9 homeobox gene protein, mouse |
| OG9 homeobox gene protein, rat |
| OG9X |
| Og9x protein, mouse |
| Og9x protein, rat |
| OGA |
| OGal-A-Glu |
| ogam |
| Oganomycin |
| oganomycin A |
| oganomycin B |
| oganomycin F |
| oganomycin G |
| oganomycin GA |
| oganomycin GB |
| oganomycin GF |
| oganomycin GG |
| oganomycin GH |
| oganomycin GI |
| oganomycin H |
| oganomycin I |
| oganomycins |
| Ogast |
| Ogastemma |
| Ogastemma pusillum |
| Ogastro |
| Ogataea |
| Ogataea chonburiensis |
| Ogataea corticis |
| Ogataea falcaomoraisii |
| Ogataea ganodermae |
| Ogataea glucozyma |
| Ogataea glucozyma (Wick.) Y. Yamada, K. Maeda & Mikata 1994 |
| Ogataea henricii |
| Ogataea henricii (Wick.) Y. Yamada, K. Maeda & Mikata 1994 |
| Ogataea nakhonphanomensis |
| Ogataea neopini |
| Ogataea pini |
| Ogataea pini (Holst) Y. Yamada, M. Matsuda, K. Maeda & Mikata 1995 |
| Ogataea polymorpha |
| Ogataea siamensis |
| Ogataea sp. NCAIM Y.01833 |
| Ogataea sp. NCAIM Y.01835 |
| Ogataea sp. NCAIM Y.01837 |
| Ogataea sp. NCAIM Y.01853 |
| Ogataea sp. TN-2008 |
| Ogataea thermomethanolica |
| Ogataea zsoltii |
| OGC |
| OGC transport protein |
| Ogcocephalidae |
| Ogcocephalioidei |
| Ogcocephalus |
| Ogcocephalus nasutus |
| Ogcocephalus parvus |
| Ogcocephalus parvus Longley & Hildebrand, 1940 |
| Ogcodes |
| Ogcodes basalis |
| Ogcodes canadensis |
| Ogcodes leptisoma |
| Ogcodes sp. 98-09-21-47 |
| Ogcodes sp. 99-07-21-51 |
| Ogcodes sp. LRC-2002 |
  29 30 31 32 33   |
